Division of Neuropsychiatry, Centro de Ciências Médicas, Universidade Federal de Pernambuco (UFPE), Recife, Brazil; Headache Clinic, Hospital Universitario Oswaldo Cruz, Universidade de Pernambuco, Recife, Brazil.
Neurol Clin. 2024 May;42(2):507-520. doi: 10.1016/j.ncl.2023.12.006. Epub 2024 Jan 12.
Headache affects around half of patients in the acute phase of COVID-19 and generally occurs at the beginning of the symptomatic phase, has an insidious onset, and is bilateral, and of moderate to severe intensity. COVID-19 may also present complications that cause acute and persistent headaches, such as cerebrovascular diseases, rhinosinusitis, meningitis, and intracranial hypertension. In 10% to 20% of patients with COVID-19, headache may persist beyond the acute phase. In general, the headache improves over time. To date, there are no clinical trials that have assessed the treatment of persistent post-COVID-19 headache.
头痛影响约一半 COVID-19 急性期患者,通常发生在症状出现初期,呈隐袭性起病,双侧性,程度为中重度。COVID-19 还可能引起引起急性和持续性头痛的并发症,如脑血管病、鼻-鼻窦炎、脑膜炎和颅内压增高。在 10%至 20%的 COVID-19 患者中,头痛可能会持续到急性期之后。一般而言,头痛会随时间逐渐缓解。迄今为止,尚无评估持续性 COVID-19 后头痛治疗的临床试验。